Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Positron emission tomography superior to standard evaluation tools in measuring treatment response

04.02.2008
Standard evaluation imaging missed 80 percent of responders

Positron Emission Tomography (PET) was much more sensitive and more accurate than conventional imaging methods in detecting response to treatment in sarcoma patients, according to a UCLA study that is among the first to directly compare PET to CT scanning.

The study has important implications for patients. If conventional imaging fails to detect treatment response, oncologists may discontinue therapies that in fact are working and study participants may be dismissed from clinical trials that are actually helping them. Conversely, if a patient is not responding, using PET scanning to evaluate response could help prevent them from undergoing toxic therapies that aren’t working.

The study, conducted by a multidiscplinary team of scientists at UCLA’s Jonsson Cancer Center, appears in the Feb. 1, 2008 issue of Clinical Cancer Research. Researchers found that standard size-based evaluation methods only identified 20 percent of responders, while PET was able to identify responders 100 percent of the time.

Current practice evaluates response to treatment using RECIST, or Response Evaluation Criteria in Solid Tumors. Patients are scanned using CT or MRI before and after treatment and the scans are then compared to determine if the tumor has decreased in size. If there is no change, the disease is considered stable. A partial response is tumor shrinkage of more than 30 percent, while a total response is tumor elimination.

“We knew from our considerable experience with neoadjuvant therapy (treatment before surgery) in sarcoma patients, that measuring tumor size correlated poorly with response,” said Dr. Fritz Eilber, an assistant professor of surgery, director of the Sarcoma Program at UCLA’s Jonsson Cancer Center and senior author of the study. “We have removed many tumors that have not changed in size with treatment or have even grown, but are completely dead on pathologic analysis. Just because the tumor doesn’t shrink doesn’t mean the treatment didn’t work.”

Eilber and his team of top scientists, including PET scan inventor Michael Phelps, wanted to find a better way to predict response so patients would not have to undergo unnecessary treatment or be removed from therapies that were working. Since operable sarcomas are treated before surgery with chemotherapy and radiation, it was the ideal cancer in which to compare PET scanning to CT.

CT and MRI scans provide anatomical pictures of the body, while PET images many different biochemical functions in real time, acting as a sort of molecular camera. Unlike CT and MRI, PET doesn’t just take a snapshot of body structures, it watches what the body is doing.

In this study, researchers measured the metabolic activity of the tumor, or how much sugar was being consumed in the cancer cells. Cancer cells, because they’re growing uncontrollably, use much more sugar than do normal cells. Using a specific PET probe that measures sugar metabolism, researchers could determine whether the cancer cells in the tumor were still alive and dividing after chemotherapy and radiation, Eilber said.

Researchers used a PET/CT scanner in the study, a technologic advance that combines the imaging modalities in one machine. The combined scanner allowed researchers to directly compare the before and after treatment scans for both tumor size and metabolic activity.

“PET was much more sensitive in picking up response than size-based RECIST,” Eilber said. “RECIST missed a large percentage of patients that actually had a response. PET picked up all of the responders.”

The study also has important implications for long-term patient follow-up, Eilber said. PET scanning quickly tells doctors how much of the tumor is dead. The amount of tumor that dies during treatment correlates with patient outcomes. If a large amount of the tumor is killed during treatment, sarcoma patients experience increased survival and lower recurrence rates.

This form of monitoring response to treatment also will be important in evaluating patients whose cancers have spread throughout the body, Eilber said.

“Evaluating biologic responses to therapy is the future of cancer imaging,” he said.

Eilber and his team already are working to confirm their results in a larger study and are testing new metabolic tracers to assess treatment response.

The study represented a true multidisciplinary effort, Eilber said. Experts from surgery, medical oncology, radiology, pathology, orthopedics, nuclear medicine and biostatistics comprised the research team.

Kim Irwin | EurekAlert!
Further information:
http://www.mednet.ucla.edu

More articles from Studies and Analyses:

nachricht Drone vs. truck deliveries: Which create less carbon pollution?
31.05.2017 | University of Washington

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

Im Focus: Optoelectronic Inline Measurement – Accurate to the Nanometer

Germany counts high-precision manufacturing processes among its advantages as a location. It’s not just the aerospace and automotive industries that require almost waste-free, high-precision manufacturing to provide an efficient way of testing the shape and orientation tolerances of products. Since current inline measurement technology not yet provides the required accuracy, the Fraunhofer Institute for Laser Technology ILT is collaborating with four renowned industry partners in the INSPIRE project to develop inline sensors with a new accuracy class. Funded by the German Federal Ministry of Education and Research (BMBF), the project is scheduled to run until the end of 2019.

New Manufacturing Technologies for New Products

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

A new technique isolates neuronal activity during memory consolidation

22.06.2017 | Life Sciences

Plant inspiration could lead to flexible electronics

22.06.2017 | Materials Sciences

A rhodium-based catalyst for making organosilicon using less precious metal

22.06.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>